Stuart B. Parker Sells 25,000 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

HealthEquity Trading Up 0.7 %

HQY opened at $95.62 on Monday. The stock has a market capitalization of $8.29 billion, a P/E ratio of 87.72, a P/E/G ratio of 1.10 and a beta of 0.55. HealthEquity, Inc. has a 12 month low of $62.10 and a 12 month high of $105.82. The firm’s fifty day simple moving average is $94.06 and its 200 day simple moving average is $84.26. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

Analyst Ratings Changes

A number of research analysts have commented on HQY shares. Bank of America raised their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada lifted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

View Our Latest Stock Report on HealthEquity

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently added to or reduced their stakes in HQY. SG Americas Securities LLC lifted its position in HealthEquity by 48.5% during the 2nd quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock worth $327,000 after buying an additional 1,241 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in shares of HealthEquity in the 2nd quarter valued at about $265,000. Gradient Investments LLC raised its holdings in shares of HealthEquity by 2.3% in the 2nd quarter. Gradient Investments LLC now owns 54,849 shares of the company’s stock valued at $4,728,000 after purchasing an additional 1,218 shares during the period. Raymond James & Associates raised its holdings in shares of HealthEquity by 11.3% in the 2nd quarter. Raymond James & Associates now owns 149,407 shares of the company’s stock valued at $12,879,000 after purchasing an additional 15,140 shares during the period. Finally, Vaughan Nelson Investment Management L.P. raised its holdings in shares of HealthEquity by 1.8% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 616,860 shares of the company’s stock valued at $53,173,000 after purchasing an additional 11,150 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.